期刊文献+
共找到178篇文章
< 1 2 9 >
每页显示 20 50 100
超声造影联合MRI融合导航技术在评估肝细胞肝癌消融疗效中的临床价值
1
作者 张琪 王坤 +4 位作者 曹佳颖 经翔 严昆 董怡 王文平 《临床超声医学杂志》 CSCD 2024年第2期100-104,共5页
目的探讨超声造影(CEUS)联合MRI融合导航技术在评估肝细胞肝癌(HCC)消融疗效中的临床应用价值。方法前瞻性选取2020年9月至2022年12月我院、天津市第三中心医院及北京大学附属肿瘤医院行消融治疗的HCC患者77例,随机分为CEUS组46例(46个... 目的探讨超声造影(CEUS)联合MRI融合导航技术在评估肝细胞肝癌(HCC)消融疗效中的临床应用价值。方法前瞻性选取2020年9月至2022年12月我院、天津市第三中心医院及北京大学附属肿瘤医院行消融治疗的HCC患者77例,随机分为CEUS组46例(46个病灶)和CEUS联合MRI导航组31例(31个病灶),分别于消融前1 d及消融后30 d行CEUS或CEUS联合MRI融合导航检查。以消融后30 d普美显增强MRI为标准,比较两组消融疗效情况。结果CEUS组46个病灶中,39个完全消融,其中32个病灶达到安全边界;CEUS联合MRI导航组31个病灶中,27个完全消融,且均达到安全边界,两组消融疗效比较差异无统计学意义(P=0.063)。CEUS组中,7个未完全消融,CEUS准确诊断5个;CEUS联合MRI导航组中,MRI诊断3个未消融完全,CEUS联合MRI导航技术诊断4个未消融完全。CEUS联合MRI导航融合成功率为100%。位于特殊位置(距离肝包膜、大血管旁、胆囊旁、膈肌<5 mm)的病灶中,CEUS组中79.3%(23/29)的病灶达到安全边界,CEUS联合MRI导航组中88.2%(15/17)的病灶达到安全边界,两组比较差异有统计学意义(P<0.001)。消融前二维超声呈等回声或边界不清晰的病灶中,CEUS组中80.0%(20/25)的病灶达到安全边界,CEUS联合MRI导航组中88.9%(16/18)病灶达到安全边界,两组比较差异有统计学意义(P<0.001)。结论CEUS联合MRI融合导航技术有助于准确判断HCC消融的安全边界,尤其对位于特殊位置的病灶及二维超声呈等回声或边界不清晰的病灶消融疗效更佳。 展开更多
关键词 超声检查 造影剂 mri 融合成像 肝细胞肝癌 消融治疗 安全边界
下载PDF
Modified DTPA, EDTA Ligands and Their Paramagnetic Metal Complexes as Contrast Agents for MRI
2
作者 Zhuo Renxi Fu Gongcheng +2 位作者 Ouyang Ming Zhao Xia Lu Zhengrong 《Wuhan University Journal of Natural Sciences》 CAS 1996年第2期225-229,共5页
Six new aminocarboxylic ligands were synthesized by reactions of EDTA (ethylenediaminetetraacetic acid) dianhydride or DTPA (dlethylenetriaminepenta-acetic acid) dianhydride and ethyl ester of serine,threonine and tyr... Six new aminocarboxylic ligands were synthesized by reactions of EDTA (ethylenediaminetetraacetic acid) dianhydride or DTPA (dlethylenetriaminepenta-acetic acid) dianhydride and ethyl ester of serine,threonine and tyrosine. Their paramagnetic metal complexes were also synthesized.All ligands and paramagnetic metal complexes were characterized by IR spectra,IH NMR and elemental analyses.Relaxivity study showed that the metal complexes had higher relaxation effectiveness as compared to corresponding unmodified metal complexes. Imaging study of gadolinium complex of tyrosine ethyl ester modified DTPA in mice demonstrated that this metal complex could apparently increase the signal intensity of MR images. 展开更多
关键词 Magnetic resonance imaging (mri) contrast agent relaxivity derivative of amino acid
下载PDF
Sonazoid超声造影与普美显增强MRI诊断肝细胞肝癌的对比研究
3
作者 张雨 汤群锋 +2 位作者 吴鸣宇 杨树东 周锋盛 《临床超声医学杂志》 CSCD 2024年第8期630-635,共6页
目的对比Sonazoid超声造影与普美显增强MRI对肝细胞肝癌(HCC)的诊断价值。方法选取我院肝脏占位性病变患者43例,共计55个病灶,其中HCC 41个,良性病灶14个。观察HCC与良性病灶的Sonazoid超声造影及普美显增强MRI图像特征,比较二者对HCC... 目的对比Sonazoid超声造影与普美显增强MRI对肝细胞肝癌(HCC)的诊断价值。方法选取我院肝脏占位性病变患者43例,共计55个病灶,其中HCC 41个,良性病灶14个。观察HCC与良性病灶的Sonazoid超声造影及普美显增强MRI图像特征,比较二者对HCC的诊断准确率、灵敏度、特异度;采用Kappa检验分析二者的一致性。结果HCC与良性病灶在动脉期、延迟期及血管后期(Kupffer期)的超声造影增强特征比较差异均有统计学意义(均P<0.05),其中HCC动脉期以高增强为主(75.61%),延迟期均呈等或低增强,Kupffer期以低增强为主(85.37%)。HCC与良性病灶在动脉期和肝胆期的增强MRI增强特征比较差异均有统计学意义(均P<0.05),其中HCC动脉期以高信号为主(65.85%),肝胆期以低信号为主(73.17%)。Sonazoid超声造影和普美显增强MRI对HCC的诊断准确率、灵敏度、特异度分别为87.27%、90.24%、78.57%和90.91%、92.68%、85.71%,二者比较差异均无统计学意义。Sonazoid超声造影与普美显增强MRI诊断HCC的一致性好(Kappa=0.908)。结论Sonazoid超声造影对HCC的诊断效能与普美显增强MRI相当。 展开更多
关键词 超声检查 造影剂 SONAZOID 普美显增强mri 肝脏占位性病变 肝细胞肝癌
下载PDF
荧光-磁共振双功能纳米探针FITC-CS-LA@SPION的制备及体外MRI成像 被引量:1
4
作者 夏雷 全姬善 +3 位作者 李德奇 龙彦军 刘岩 金光玉 《延边大学医学学报》 CAS 2015年第1期39-43,共5页
[目的]制备肝细胞表面去唾液酸糖蛋白受体(ASGP-R)特异性荧光-磁共振双功能纳米探针(FITC-CS-LA@SPION),探讨其与体外肝细胞靶向结合情况及在MRI显像中的价值.[方法]利用异硫氰酸荧光素(FITC)标记壳聚糖(CS)与乳糖酸(LA)修饰的超顺磁性... [目的]制备肝细胞表面去唾液酸糖蛋白受体(ASGP-R)特异性荧光-磁共振双功能纳米探针(FITC-CS-LA@SPION),探讨其与体外肝细胞靶向结合情况及在MRI显像中的价值.[方法]利用异硫氰酸荧光素(FITC)标记壳聚糖(CS)与乳糖酸(LA)修饰的超顺磁性氧化铁纳米颗粒(SPION)合成FITC-CS-LA@SPION,采用荧光显微镜和流式细胞仪检测FITC-CS-LA@SPION与肝细胞体外结合情况,通过体外MRI成像观察细胞数量与MRI信号变化的关系.[结果]流式细胞仪检测结果表明,FITC-CS-LA@SPION与肝细胞有较强的结合能力;荧光显微镜观察结果显示,FITC-CS-LA@SPION特异性分布于肝细胞周缘,而对照组FITC-SPION仅见少量荧光分布;体外MRI成像结果显示,T2WI信号随肝细胞数量的增加而增强.[结论]FITC-CS-LA@SPION对肝细胞具有较强的特异性结合力,且具有较好的MRI增强效果. 展开更多
关键词 mri造影剂 去唾液酸糖蛋白受体 肝脏靶向 荧光成像 双功能探针
下载PDF
一种MRI可视化介导的Fe_(3)O_(4)复合纳米体系的制备及其在肿瘤光热联合治疗中的应用
5
作者 陈郑胜男 任方丽 +1 位作者 宏伟 李文婷 《滨州医学院学报》 2024年第3期168-174,共7页
目的通过乳化-溶剂挥发法制备新型Fe_(3)O_(4)/780复合纳米粒(Fe/780 NPs),用于指导磁共振成像(MRI)可视化引导下的肿瘤光热联合治疗。方法利用动态光散射仪(DLS)和透射电子显微镜(TEM)测定Fe/780 NPs的粒径分布、微观形貌;采用近红外... 目的通过乳化-溶剂挥发法制备新型Fe_(3)O_(4)/780复合纳米粒(Fe/780 NPs),用于指导磁共振成像(MRI)可视化引导下的肿瘤光热联合治疗。方法利用动态光散射仪(DLS)和透射电子显微镜(TEM)测定Fe/780 NPs的粒径分布、微观形貌;采用近红外热成像评价Fe/780 NPs的光热转换效果,通过溶血实验评价Fe/780 NPs的生物相容性,通过检测细胞内活性氧(ROS)水平、细胞活/死双染实验和MTT实验评价体外抗肿瘤活性;采用7.0 T小动物磁共振成像仪分析复合纳米粒在肿瘤部位的MRI成像效果;通过建立4T1肿瘤细胞异位移植瘤模型,考察制剂的体内联合抑瘤效果。结果采用乳化-溶剂挥发法成功制备高效共载IR780和MNPs的递送纳米体系,纳米颗粒粒径分布均一,MNPs的加入使体系的光热转换性能明显优于单一光敏剂,减少了光敏剂用量,使生物毒性降低,并且升温过程更加温和,避免了过高热的产生。在体内外抗肿瘤实验过程中表现出很好的抗肿瘤活性,能够靶向到肿瘤部位并且具有良好的MRI成像能力。结论Fe/780 NPs可用于MRI可视化介导的肿瘤光热联合治疗,使癌症的诊断和治疗更加准确。 展开更多
关键词 纳米颗粒 抗肿瘤 光热疗法 磁共振造影剂
下载PDF
Hybrid Dextran-gadolinium Nano-suitcases as High-relaxivity MRI Contrast Agents 被引量:2
6
作者 Hao Wang Ting-Ting Dai +4 位作者 Bo-Lun Lu Sheng-Li Li Qing Lu Vincent Mukwaya Hong-Jing Dou 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2018年第3期391-398,共8页
Dextran-poly(glycidyl methacrylate) (Dex-PGMA) nano-suitcases were synthesized efficiently via a graft copolymerization induced self-assembly (GISA) approach. On this basis, the Dex-PGMA nano-suitcases were modi... Dextran-poly(glycidyl methacrylate) (Dex-PGMA) nano-suitcases were synthesized efficiently via a graft copolymerization induced self-assembly (GISA) approach. On this basis, the Dex-PGMA nano-suitcases were modified with hydrazide, and the attachment of multiple chelated Gd(III) ions to the interior of the nano-suitcases affords nanoscale MRI contrast agents with high relaxivity values. The highly fenestrated dextran shell of the nano-suitcases assures water exchange which readily occurs between the surrounding environment and the Gd(III) ions encapsulated within the hybrid nano-suitcases. The complexation between the hydrophilic hydrazide interior of the nano-suitcases and Gd(III) ions results in an impressive Gd payload at 22.6 wt% in the hybrid nano-suitcases. The longitudinal relaxivity (rl) of the hybrid nano-suitcases is reported as 44.4 L/(mmol-s), which is 9-14 folds of that of commercial Gd-DTPA agents. In vivo MRI studies demonstrate that the hybrid nano-suitcases accumulated in the lymph node of the rat due to their nanoscale dimensions and displayed strong signals in vivo. The results indicated that the hybrid nano-suitcases provide a promising platform for the diagnosis of lymph node related diseases. 展开更多
关键词 Crosslinked polymer nanoparticles Gadolinium(llI) mri contrast agents Lymph node imaging
原文传递
Synthesis and in vitro Evaluation of Manganese(Ⅱ)-porphyrin Modified with Chitosan Oligosaccharides as Potential MRI Contrast Agents 被引量:1
7
作者 LIU Yun HUANG Yan +3 位作者 BOAMAH Peter Osei ZHANG Qi LIU Yuanyuan HUA Mingqing 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2014年第4期549-555,共7页
Mn-TCPP-CSn(n=6,1 1,20) as a type of potential magnetic resonance imaging(MRI) contrast agents were synthesized via manganese(Ⅱ) meso-tetra(4-carboxyphenyl) porphyrin(Mn-TCPP) modified with chitosan oligosa... Mn-TCPP-CSn(n=6,1 1,20) as a type of potential magnetic resonance imaging(MRI) contrast agents were synthesized via manganese(Ⅱ) meso-tetra(4-carboxyphenyl) porphyrin(Mn-TCPP) modified with chitosan oligosaccharides(CSn).Experimental data of infared(IR),UV-Vis,MS,inductively coupled plasma-atomic emission spectrometer(ICP-AES) and size exclusion chromatography evidenced the formation of Mn-TCPP-CSn-The stability results show that Mn-TCPP-CSn in aqueous solution was stable enough to prevent Mn(Ⅱ) ions from leaking.The magnetic properties in vitro indicate that Mn-TCPP-CS20 possesses higher longitudinal relaxivity(r1=10.38 L·mmol^-1·s^-1) in aqueous solution than unmodified porphyrin Mn-TCPPNa4[manganese(Ⅱ) meso-tetra(4-carboxyphenyl) porphyrin,tetrasodium salt](r1=5.10 L·mmol^-1·s^-1) and the commercial contrast agent Gd-DTPA(r1=4.05 L·mmol^-1·s^-1).The preliminary T1-weighted flash image studies in vitro show that the contrast and the imaging signal of Mn-TCPP-CSn were superior to those of Mn-TCPPNa4 and Gd-DTPA under the same conditions.The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay shows that Mn-TCPP-CSn has a good biocompatibility.In addition,the thermodynamical parameters(ΔH〈0,ΔS〈0,ΔG〈0) of Mn-TCPP-CSn bound to bovine serum albumin(BSA) show that Mn-TCPP-CSn could bind to BSA spontaneously,where the binding complex was stabilized mainly by van der Waals interactions and hydrogen bonds.These results suggest that Mn-TCPP-CSn have the advantage of becoming a potential MRI contrast agent. 展开更多
关键词 mri contrast agent PORPHYRIN Chitosan oligosaccharide RELAXIVITY T1-Weighted flash image
原文传递
A novel nitroreductase-enhanced MRI contrast agent and its potential application in bacterial imaging 被引量:1
8
作者 Yun Liu Leilei Zhang +2 位作者 Marc Nazare Qingqiang Yao Hai-Yu Hu 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2018年第3期401-408,共8页
Nitroreductases(NTRs) are known to be able to metabolize nitro-substituted compounds in the presence of reduced nicotinamide adenine dinucleotide(NADH) as an electron donor. NTRs are present in a wide range of bacteri... Nitroreductases(NTRs) are known to be able to metabolize nitro-substituted compounds in the presence of reduced nicotinamide adenine dinucleotide(NADH) as an electron donor. NTRs are present in a wide range of bacterial genera and, to a lesser extent, in eukaryotes hypoxic tumour cells and tumorous tissues, which makes it an appropriate biomarker for an imaging target to detect the hypoxic status of cancer cells and potential bacterial infections. To evaluate the specific activation level of NTR, great efforts have been devoted to the development of fluorescent probes to detect NTR activities using fluorogenic methods to probe its behaviour in a cellular context; however, NTR-responsive MRI contrast agents are still by far underexplored. In this study, para-nitrobenzyl substituted T_1-weighted magnetic resonance imaging(MRI)contrast agent Gd-DOTA-PNB(probe 1) has been designed and explored for the possible detection of NTR.Our experimental results show that probe 1 could serve as an MRI-enhanced contrast agent for monitoring NTR activity. The in vitro response and mechanism of the NTR catalysed reduction of probe 1 have been investigated through LC–MS and MRI. Para-nitrobenzyl substituted probe 1 was catalytically reduced by NTR to the intermediate para-aminobenzyl substituted probe which then underwent a rearrangement elimination reaction to Gd-DOTA, generating the enhanced T1-weighted MR imaging. Further, LC–MS and MRI studies of living Escherichia coli have confirmed the NTR activity detection ability of probe 1 at a cellular level. This method may potentially be used for the diagnosis of bacterial infections. 展开更多
关键词 NITROREDUCTASE mri contrast agent Smart imaging probes Bacterial imaging Bacterial infection
原文传递
Novel nanovectors as liver targeting MRI contrast agents
9
作者 刘永军 陈智金 张娜 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第2X期105-117,共13页
Accurate diagnosis of hepatocellular carcinoma(HCC) in the early stage is vital for its treatment.Contrast-enhanced dynamic magnetic resonance imaging(MRI) performed in the presence of extracellular contrast agents su... Accurate diagnosis of hepatocellular carcinoma(HCC) in the early stage is vital for its treatment.Contrast-enhanced dynamic magnetic resonance imaging(MRI) performed in the presence of extracellular contrast agents such as gadolinium chelates is considered as a useful approach for detecting and characterizing focal liver lesions.However,the sensitivity and specificity of conventional MRI contrast agents are far from satisfaction for the detection and characterization of benign and malignant focal liver lesions in the early stage.The novel molecular contrast agents special for liver with relatively longer metabolic time and stable contrast effect in liver tissue are highly desired.The development of nanotechnology provides an unprecedented opportunity for the diagnostic detection rate of HCC and cell-surface receptor-targeted nanotechnology improves the specificity of the detection of focal liver lesions.In order to maximize lesion detection and characterization,novel gadolinium chelates loaded nanovectors including the solid lipid nanoparticles,nanocomplexes and polymeric nanoparticles have been used as biocompatible molecular MRI contrast agent.In this review,the characterization and the advantages/disadvantages of these Gd-loaded novel nanovectors used as molecular MRI contrast agents were discussed.Furthermore,liver target nanovectors aimed at improving the diagnostic accuracy of liver MRI by targeting additional features of focal liver lesions were highlighted. 展开更多
关键词 Hepatocellular carcinoma Molecular imaging contrast agent GADOLINIUM mri
原文传递
PAA-capped GdF3 nanoplates as dual-mode MRI and CT contrast agents 被引量:4
10
作者 Xiao-Yu Zheng Ling-Dong Sun Tao Zheng Hao Dong Yang Li Ye-FuWang Chun-Hua Yan 《Science Bulletin》 SCIE EI CAS CSCD 2015年第12期1092-1100,I0002,共10页
Aiming at improving the sensitivity and accu- racy 9f diagnosis, the combination of magnetic resonance imaging (MRI) and X-ray computed tomography (CT) in a single probe is in urgent need. Here, we report the deve... Aiming at improving the sensitivity and accu- racy 9f diagnosis, the combination of magnetic resonance imaging (MRI) and X-ray computed tomography (CT) in a single probe is in urgent need. Here, we report the devel- opment of polyacrylic acid (PAA)-capped GdF3 nanoplates (NPs) as novel MRI and CT dual-mode contrast agents (CAs) with high longitudinal relaxivity (rl) and large X-ray attenuation coefficient. Uniform GdF3 rhombic NPs were fabricated by controlling reaction conditions and intro- ducing dopants. The average size of GdF3 NPs is (10.6 :k 1.1) nm in long diagonal, (7.0 -t- 0.8) nm in short diagonal, and (4.2 -4- 1.2) nm in thickness. Ligand-exchange treat- ment was performed to render the NPs water-dispersible. The rl of PAA-capped GdF3 NPs (15.8 L/(mmol s)) is four times higher than that of clinically used Gd-DTPA. We suppose that the high r~ value originates from the con- struction of two-dimensional (2D) nanostructures, which endows nanocrystals with larger surface areas and longer rotational correlation time than those of sphere nanostruc- tures with the same volume. The CT contrast enhancement ability of PAA-capped GdF3 NPs was evaluated in com- parison with clinically used Iohexol. The above results suggest that the PAA-capped GdF3 NPs could serve as CAs for MRI and CT dual-mode imaging. 展开更多
关键词 NANOPLATES GdF3 contrast agent mri CT
原文传递
MRI特异性对比剂——普美显增强MRI在肝脏疾病诊断中的应用现状 被引量:1
11
作者 陈好 古素娟 缪淑芳 《世界复合医学》 2023年第8期191-194,共4页
肝脏疾病是临床中比较常见的疾病类型,引起肝脏损伤的原因通常为病毒性感染,包含乙型、丙型肝炎、巨细胞病毒、腺病毒等。肝脏疾病的早期诊断极其重要,早诊断早治疗可帮助患者防止病情发展。影像学技术在肝脏疾病的诊断中意义重大,其中... 肝脏疾病是临床中比较常见的疾病类型,引起肝脏损伤的原因通常为病毒性感染,包含乙型、丙型肝炎、巨细胞病毒、腺病毒等。肝脏疾病的早期诊断极其重要,早诊断早治疗可帮助患者防止病情发展。影像学技术在肝脏疾病的诊断中意义重大,其中磁共振成像(magnetic resonance imaging, MRI)、电子计算机断层扫描技术(computed tomography, CT)这两种诊断技术最临床应用率较高,现阶段已成为肝脏疾病诊断的常用方法。磁共振存在良好的组织对比性,临床使用价值高。本文就MRI特异性对比剂——普美显增强MRI在肝脏疾病诊断中的应用现状展开综述。 展开更多
关键词 mri特异性对比剂——普美显 磁共振 肝脏疾病 准确性
下载PDF
铁配合物MRI造影剂的研究进展
12
作者 颜靖宜 杨景霞 焦静静 《上海师范大学学报(自然科学版中英文)》 2023年第6期697-704,共8页
因钆(Gd)基造影剂潜在的毒副作用,人们一直在寻找其他的替代品.目前研究较深入的有铁(Fe)、锰(Mn)等金属造影剂,以及氙(^(129)Xe)、氟(^(19)F)等非金属造影剂.Fe配合物作为一类纵向(T1)加权磁共振成像(MRI)造影剂,具有良好的生物相容性... 因钆(Gd)基造影剂潜在的毒副作用,人们一直在寻找其他的替代品.目前研究较深入的有铁(Fe)、锰(Mn)等金属造影剂,以及氙(^(129)Xe)、氟(^(19)F)等非金属造影剂.Fe配合物作为一类纵向(T1)加权磁共振成像(MRI)造影剂,具有良好的生物相容性,在临床上有极大的潜在应用价值.文章着重介绍了此类造影剂在弛豫性能、特异性响应成像、多模态联合成像方面的研究进展,通过对铁离子个数的调节与配体的修饰,以提高其弛豫性能;通过添加不同功能的基团,可对某些癌症或其他患病区域进行靶向成像;以及与其他成像方式,如光声成像、荧光成像等进行的联合诊断. 展开更多
关键词 铁配合物 磁共振成像(mri) 造影剂
下载PDF
Volume-related Efficiency of Gadolinium Polyoxometalates as MRI Contrast Agents
13
作者 KONG Da-liang WEI Bo ZHOU Sheng-yan YANG Hai-shan JIANG Yang 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2013年第6期1055-1058,共4页
Two gadolinium polyoxometalates, KCs4[Gd(a-SiW11O39)].25HzO(POM-1) and K13[Gd(f12-SiWllO39)a]·27H2O(POM-2), have been evaluated as the candidates of potential magnetic resonance imaging Tl(longitudinal r... Two gadolinium polyoxometalates, KCs4[Gd(a-SiW11O39)].25HzO(POM-1) and K13[Gd(f12-SiWllO39)a]·27H2O(POM-2), have been evaluated as the candidates of potential magnetic resonance imaging Tl(longitudinal relaxation) contrast agents. Longitudinal relaxivities of POM-2 are much higher than those of POM-1 in pure water and protein solution, respectively. However, compared with POM-1, POM-2 interacts with protein more strongly through electrostatic interaction, which is comfirmed by the fluoresence quenching of human serum albumin(HSA) in solu- tions with different polyoxometalate concentrations. Meanwhile, POM-1 presentes much lower cytotoxicity in the cell viability tests. 展开更多
关键词 Magnetic resonance imaging(mri contrast agent POLYOXOMETALATE
原文传递
Novel nanovectors as liver targeting MRI contrast agents
14
作者 Yong-Jun Liu Zhi-Jin Chen Na Zhang 《Journal of Chinese Pharmaceutical Sciences》 CAS 2011年第2期105-117,共13页
Accurate diagnosis of hepatocellular carcinoma (HCC) in the early stage is vital for its treatment. Contrast-enhanced dynamic magnetic resonance imaging (MRI) performed in the presence of extracellular contrast ag... Accurate diagnosis of hepatocellular carcinoma (HCC) in the early stage is vital for its treatment. Contrast-enhanced dynamic magnetic resonance imaging (MRI) performed in the presence of extracellular contrast agents such as gadolinium chelates is considered as a useful approach for detecting and characterizing focal liver lesions. However, the sensitivity and specificity of conventional MRI contrast agents are far from satisfaction for the detection and characterization of benign and malignant focal liver lesions in the early stage. The novel molecular contrast agents special for liver with relatively longer metabolic time and stable contrast effect in liver tissue are highly desired. The development of nanotechnology provides an unprecedented opportunity for the diagnostic detection rate of HCC and cell-surface receptor-targeted nanotechnology improves the specificity of the detection of focal liver lesions. In order to maximize lesion detection and characterization, novel gadolinium chelates loaded nanovectors including the solid lipid nanoparticles, nanocomplexes and polymeric nanoparticles have been used as biocompatible molecular MRI contrast agent. In this review, the characterization and the advantages/disadvantages of these Gd-loaded novel nanovectors used as molecular MRI contrast agents were discussed. Furthermore, liver target nanovectors aimed at improving the diagnostic accuracy of liver MR1 by tar~etin~ additional features of focal liver lesions were highlighted. 展开更多
关键词 Hepatocellular carcinoma Molecular imaging contrast agent GADOLINIUM mri
原文传递
肩袖损伤患者MRI和MR肩关节造影的诊断价值比较 被引量:44
15
作者 石俊岭 崔建岭 +5 位作者 孙英彩 孟凯龙 张岭岭 郭俊萍 王炜 徐静 《中国CT和MRI杂志》 2016年第5期129-131,共3页
目的比较肩袖损伤患者MRI和MR肩关节造影的诊断价值。方法以2013年7月-2014年12月前来我院就诊106例疑似肩袖损伤患者进行研究,均行MRI检查,随后有55例行肩关节MR造影检查,其中20例高度疑似病例再接受关节镜诊治确诊。比较MRI和MR的诊... 目的比较肩袖损伤患者MRI和MR肩关节造影的诊断价值。方法以2013年7月-2014年12月前来我院就诊106例疑似肩袖损伤患者进行研究,均行MRI检查,随后有55例行肩关节MR造影检查,其中20例高度疑似病例再接受关节镜诊治确诊。比较MRI和MR的诊断准确性。结果 20例行关节镜检查患者确诊为12例肩袖部分撕裂、5例肩袖全层撕裂、3例肩袖变性,其中6例为肩袖撕裂并发盂唇损伤,MRI确诊准确性为55(11/20),明显低于MRar的100.0%(20/20),比较有统计学意义(χ2=11.613,P=0.000<0.05)。结论虽然MRI与MRar均无法较好显示肩袖钙化情况,但MRar在肩袖损伤临床诊断中的应用具有更高准确性,可作为首先诊断方法。 展开更多
关键词 肩袖损伤 mri MRar 对比剂 关节腔积液
下载PDF
经直肠双重超声造影、CT、MRI检查在直肠癌淋巴结转移中的应用价值 被引量:12
16
作者 罗晓茂 谭蜀川 +3 位作者 陈海涛 张圆 邵晖 杨丽春 《临床超声医学杂志》 2016年第6期389-392,共4页
目的探讨经直肠双重超声造影、CT、MRI检查在直肠癌术前淋巴结转移中的应用价值。方法对48例直肠癌患者术前行经直肠双重造影,其中42例同时行CT检查,39例同时行MRI检查,分别对区域淋巴结转移情况进行N分期,并与术后病理比较。结果经直... 目的探讨经直肠双重超声造影、CT、MRI检查在直肠癌术前淋巴结转移中的应用价值。方法对48例直肠癌患者术前行经直肠双重造影,其中42例同时行CT检查,39例同时行MRI检查,分别对区域淋巴结转移情况进行N分期,并与术后病理比较。结果经直肠双重超声造影、CT及MRI诊断N分期的准确率分别为77.1%(37/48)、81.0%(34/42)及79.5%(31/39),三者比较差异无统计学意义。结论经直肠双重超声造影、CT、MRI均是术前诊断和评价直肠癌淋巴结转移情况的有效方法。 展开更多
关键词 超声检查 经直肠 造影剂 CT mri 直肠癌
下载PDF
超声双重造影与增强MRI在直肠癌局部分期中的对比研究 被引量:5
17
作者 陈双喜 范小明 +1 位作者 王力 李锋之 《临床超声医学杂志》 2015年第8期542-544,共3页
目的评价超声双重造影(DCUS)与增强MRI在直肠癌术前局部分期中的应用价值。方法 76例直肠癌患者术前经直肠腔内灌注胃肠超声造影剂和静脉注射微泡造影剂行DCUS及MRI增强扫描,将分期结果与术后病理对照。结果术前DCUS与增强MRI对T分期的... 目的评价超声双重造影(DCUS)与增强MRI在直肠癌术前局部分期中的应用价值。方法 76例直肠癌患者术前经直肠腔内灌注胃肠超声造影剂和静脉注射微泡造影剂行DCUS及MRI增强扫描,将分期结果与术后病理对照。结果术前DCUS与增强MRI对T分期的准确性分别为82.9%、78.9%,对N分期的准确性分别为71.1%、78.9%,差异均无统计学意义。其中DCUS对T1、T2、T3、T4分期的准确性分别为84.6%、63.6%、86.8%、85.7%;增强MRI对T1、T2、T3、T4分期的准确性分别为53.8%、45.5%、92.1%、92.8%。两种检查方法局部分期一致性较好,T分期和N分期Kappa值分别为0.842、0.629(P<0.01)。结论 DCUS作为一种新的增强影像学方法,对直肠癌局部分期与增强MRI无统计学差异,两种方法 T分期具有高度一致性,N分期具有中度一致性。 展开更多
关键词 超声检查 造影剂 mri 直肠肿瘤 分期
下载PDF
口服胃肠道对比剂在MRI中的应用 被引量:4
18
作者 梁宗辉 冯晓源 +3 位作者 李克 耿道颖 黎元 蒋胜洪 《中国医学计算机成像杂志》 CSCD 2002年第3期183-186,共4页
目的 :研究应用口服胃肠道对比剂后 ,腹部MRI检查图像质量的改善。材料和方法 :以葡萄糖酸亚铁糖浆溶液为对比剂 ,经体外试验确定适宜的浓度 ;并进行临床试验 ,将50例受检者随机分为2组 ,分别口服葡萄糖酸亚铁糖浆溶液和水作为胃肠道对... 目的 :研究应用口服胃肠道对比剂后 ,腹部MRI检查图像质量的改善。材料和方法 :以葡萄糖酸亚铁糖浆溶液为对比剂 ,经体外试验确定适宜的浓度 ;并进行临床试验 ,将50例受检者随机分为2组 ,分别口服葡萄糖酸亚铁糖浆溶液和水作为胃肠道对比剂 ,采用FSE序列 ,横断面T1WI ,PWI ,T2WI ,所得图像与水作为对比剂时的图像对比研究。结果 :以葡萄糖酸亚铁糖浆溶液作对比剂时 ,在T1WI,PWI ,T2WI上 ,胃肠道均呈现高信号 ,胃肠道结构及腹部实质脏器显示清晰 ,优于以水作为胃肠道对比剂时的图像。结论 :使用合适的胃肠道对比剂 。 展开更多
关键词 mri 胃肠道 对比剂 应用 磁共振成像
下载PDF
肝胆特异性MRI对比剂评价肝功能的研究进展 被引量:4
19
作者 孙艳(综述) 王涛(审校) 《医学影像学杂志》 2020年第6期1101-1104,共4页
术前对肝功能进行准确且高效的评价已越来越受到临床的关注与重视。现阶段临床常规使用的评价肝功能的方法仍有许多的局限性。近几年,肝胆特异性MRI对比剂使用越来越广泛,在肝功能的评价方面也有了许多新的发现与突破。本篇文章着重于... 术前对肝功能进行准确且高效的评价已越来越受到临床的关注与重视。现阶段临床常规使用的评价肝功能的方法仍有许多的局限性。近几年,肝胆特异性MRI对比剂使用越来越广泛,在肝功能的评价方面也有了许多新的发现与突破。本篇文章着重于肝胆特异性MRI对比剂为基础的肝功能评价的新进展为重点,讨论其在临床中的具体应用做一综述。 展开更多
关键词 磁共振成像 肝胆特异性mri对比剂 肝功能
下载PDF
耐高压留置针在CT/MRI增强检查中的应用价值研究 被引量:5
20
作者 凌明 钮富云 《川北医学院学报》 CAS 2021年第8期1076-1078,共3页
目的:探讨耐高压留置针在计算机断层扫描/磁共振成像(CT/MRI)增强检查中的应用价值。方法:选取1 000例行CT/MRI增强检查的患者为研究对象,依据留置针不同分为对照组和观察组,每组各500例。增强扫描检查注入造影剂时,观察组患者使用耐高... 目的:探讨耐高压留置针在计算机断层扫描/磁共振成像(CT/MRI)增强检查中的应用价值。方法:选取1 000例行CT/MRI增强检查的患者为研究对象,依据留置针不同分为对照组和观察组,每组各500例。增强扫描检查注入造影剂时,观察组患者使用耐高压留置针;对照组使用常规静脉留置针,比较两组患者进入检查室到开始CT/MRI检查所用时间(T_(1))及检查结束到离开检查室所用时间(T_(2))、造影剂外渗发生率、不良事件发生率及满意度。结果:观察组T_(1)、T_(2)及总耗时、造影剂外渗发生率及护理不良事件总发生率低于对照组(P<0.05),总满意率高于对照组(P<0.05)。结论:在CT/MRI增强检查中使用耐高压留置针可减少外渗发生率,缩短护理耗时,减少不良事件发生风险,提高满意度。 展开更多
关键词 耐高压留置针 CT/mri增强检查 造影剂外渗 应用价值
下载PDF
上一页 1 2 9 下一页 到第
使用帮助 返回顶部